iAnthus Capital Holdings (IAN) AI Stock Analysis

• Market Cap: $34.09M
• Dividend Yield: N/A
• Average Volume (3M): 56.04K
• Price to Earnings (P/E): 20.0
• Beta (1Y): -4.89
• Revenue Growth: -6.05%
• EPS Growth: N/A
• Country: CA
• Employees: 716
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): >-0.01
• Shares Outstanding: 6,817,461,400
• 10 Day Avg. Volume: 132,352
• 30 Day Avg. Volume: 56,044
• PEG Ratio: 0.07
• Price to Book (P/B): -0.69
• Price to Sales (P/S): 0.27
• P/FCF Ratio: 6.47
• Enterprise Value/Market Cap: 10.77
• Enterprise Value/Revenue: 2.42
• Enterprise Value/Gross Profit: 5.26
• Enterprise Value/Ebitda: 16.28
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 38 Underperform
• Price Target: <C$0.01 ▼(-10.00% Downside)

The overall stock score is primarily impacted by significant financial challenges, including declining revenues, high leverage, and negative cash flow. The technical analysis offers limited insights due to missing data, and the valuation is moderate but overshadowed by financial instability. The absence of earnings call and corporate events data limits additional context.

Positive Factors

Product Diversity

A diverse product portfolio allows iAnthus to cater to various consumer preferences, enhancing its market position and potential for revenue growth.

Strategic Partnerships

Partnerships expand market reach and product offerings, fostering growth and competitive advantage in the cannabis industry.

Compliance and Quality Assurance

Strong compliance and quality assurance build trust and customer loyalty, supporting sustainable sales and long-term business success.

Negative Factors

Declining Revenue

Declining revenues indicate challenges in market demand or competitive positioning, potentially impacting long-term growth and profitability.

High Leverage

High leverage increases financial risk and limits flexibility, potentially affecting the company's ability to invest in growth opportunities.

Negative Cash Flow

Negative cash flow challenges the company's ability to sustain operations and invest in future growth, posing a risk to financial stability.

iAnthus Capital Holdings Business Overview & Revenue Model

Company Description

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.

How the Company Makes Money

iAnthus Capital Holdings generates revenue through multiple streams within the cannabis sector. Its primary revenue comes from the sale of cannabis products through its retail dispensaries and wholesale distribution to other licensed retailers. The company also earns income from its cultivation operations, where it grows and processes cannabis for both its own brands and third-party brands. Strategic partnerships with other cannabis operators and brands further enhance its revenue potential, allowing iAnthus to expand its market reach and product offerings. Additionally, the company's focus on compliance and quality assurance helps maintain a loyal customer base, contributing to steady sales growth.

iAnthus Capital Holdings Financial Statement Overview

Summary

iAnthus Capital Holdings faces significant financial challenges. The income statement shows declining revenues and weak profitability. The balance sheet is concerning with high leverage and negative equity. Cash flow issues further exacerbate the financial instability, highlighting the need for strategic improvements.

Income Statement

The income statement shows a declining revenue trend with a negative revenue growth rate of -3.13% in the TTM period. Gross profit margin is relatively healthy at 46.46%, but net profit margin is low at 1.62%. EBIT and EBITDA margins are weak, indicating operational challenges. Overall, the company struggles with profitability despite a decent gross margin.

Balance Sheet

The balance sheet reveals significant financial instability with a negative stockholders' equity and a high debt-to-equity ratio of -2.81 in the TTM period. Return on equity is negative, reflecting poor returns on shareholders' investments. The company is highly leveraged, posing substantial financial risk.

Cash Flow

Cash flow analysis indicates severe issues with free cash flow, which is negative and has deteriorated significantly. The operating cash flow to net income ratio is low at 0.16, and free cash flow to net income is also weak. The company faces challenges in generating sufficient cash flow to support its operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	151.41M	167.57M	159.24M	163.21M	203.02M	151.67M
Gross Profit	69.75M	75.11M	63.17M	74.43M	111.28M	86.68M
EBITDA	22.54M	21.22M	-2.59M	-369.80M	7.89M	-241.27M
Net Income	1.68M	-7.64M	-76.62M	-449.39M	-76.25M	-310.03M
Balance Sheet
Total Assets	255.95M	271.04M	277.41M	303.47M	346.74M	357.97M
Cash, Cash Equivalents and Short-Term Investments	17.21M	18.54M	13.10M	14.34M	13.24M	11.02M
Total Debt	40.24M	210.46M	201.00M	183.94M	228.54M	206.29M
Total Liabilities	345.55M	336.58M	339.07M	292.48M	369.14M	307.13M
Stockholders Equity	-89.60M	-65.54M	-61.67M	10.99M	-22.40M	50.84M
Cash Flow
Free Cash Flow	-16.56M	7.03M	-3.06M	-26.55M	-4.25M	-27.33M
Operating Cash Flow	3.04M	12.54M	3.02M	-19.50M	16.15M	-13.07M
Investing Cash Flow	6.41M	-6.28M	-3.63M	-4.74M	-21.32M	-11.49M
Financing Cash Flow	-12.38M	-339.00K	-618.00K	22.06M	10.24M	1.26M

iAnthus Capital Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EPIC	66 Neutral	$23.55M	13.51	―	―	34.71%	―
DB	63 Neutral	$77.85M	5.19	21.77%	―	15.11%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
LABS	41 Neutral	$27.35M	―	-19.10%	―	18.06%	34.58%
AVCN	41 Neutral	$28.86M	-18.28	-77.67%	―	2.41%	74.61%
AYR.A	40 Underperform	$18.10M	―	―	―	0.63%	-31.86%
IAN	38 Underperform	$34.09M	20.00	―	―	-6.05%	―

iAnthus Capital Holdings Corporate Events

iAnthus Capital Holdings Shows Improved Margins Amid Revenue Decline in Q1 2025

iAnthus Capital Holdings reported a revenue of $38.1 million for Q1 2025, marking a decline from both the previous quarter and the same period last year. Despite the revenue drop, the company saw an improvement in gross margin and a net income of $5.1 million, indicating a positive shift from a net loss in the previous year, which could signal a strengthening position in the cannabis market.